IL74921A - 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them - Google Patents

4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL74921A
IL74921A IL74921A IL7492185A IL74921A IL 74921 A IL74921 A IL 74921A IL 74921 A IL74921 A IL 74921A IL 7492185 A IL7492185 A IL 7492185A IL 74921 A IL74921 A IL 74921A
Authority
IL
Israel
Prior art keywords
tetrahydropyridines
nitrophenyl
different
preparation
pharmaceutical compositions
Prior art date
Application number
IL74921A
Other languages
English (en)
Other versions
IL74921A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL74921A0 publication Critical patent/IL74921A0/xx
Publication of IL74921A publication Critical patent/IL74921A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL74921A 1984-04-19 1985-04-16 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them IL74921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843414801 DE3414801A1 (de) 1984-04-19 1984-04-19 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
IL74921A0 IL74921A0 (en) 1985-08-30
IL74921A true IL74921A (en) 1988-03-31

Family

ID=6233988

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74921A IL74921A (en) 1984-04-19 1985-04-16 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US4621093A (xx)
EP (1) EP0158956B1 (xx)
JP (1) JPS60233057A (xx)
KR (1) KR850007590A (xx)
AT (1) ATE46147T1 (xx)
CA (1) CA1241655A (xx)
DE (2) DE3414801A1 (xx)
DK (1) DK176085A (xx)
ES (1) ES8607235A1 (xx)
IL (1) IL74921A (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE3700307A1 (de) * 1987-01-08 1988-07-21 Bayer Ag Tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1990011074A1 (en) * 1989-03-22 1990-10-04 Pang Peter K T Parathyroid hypertensive factor
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US5350771A (en) * 1989-03-22 1994-09-27 Peter K. T. Pang Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
US5514678A (en) * 1992-03-26 1996-05-07 E. I. Du Pont De Nemours And Company Arthropodicidal 1,2,4-triazinyl amides
WO2003099790A1 (en) * 2002-05-29 2003-12-04 Council Of Scientific And Industrial Research Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4361572A (en) * 1981-12-21 1982-11-30 Chugai Seiyaku Kabushiki Kaisha Tetrahydronicotinamide derivative, pharmaceutical compositions and use
DE3239273A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines

Also Published As

Publication number Publication date
EP0158956B1 (de) 1989-09-06
DK176085A (da) 1985-10-20
DE3572808D1 (en) 1989-10-12
DK176085D0 (da) 1985-04-18
IL74921A0 (en) 1985-08-30
DE3414801A1 (de) 1985-10-24
EP0158956A2 (de) 1985-10-23
US4621093A (en) 1986-11-04
EP0158956A3 (en) 1987-07-22
KR850007590A (ko) 1985-12-07
JPS60233057A (ja) 1985-11-19
ATE46147T1 (de) 1989-09-15
ES8607235A1 (es) 1986-06-01
CA1241655A (en) 1988-09-06
ES542393A0 (es) 1986-06-01

Similar Documents

Publication Publication Date Title
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
IL82039A0 (en) Phenoxyalkylcarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
IL74921A (en) 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them
ES8205791A1 (es) Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo
ES8404151A1 (es) Procedimiento para la preparacion de nuevos derivados de acidos (di)-tiofosforicos y fosfonicos.
GB2023137A (en) Derivatives of cyclohexene-1,2- dicarboxylic acid diamide and the herbicidal compositions containing them
ES8604219A1 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES2003086A6 (es) Procedimiento de obtencion de tienoquinolicinsulfonamidas
EP0205299A3 (en) Isatin derivatives, compositions containing the same, and the use thereof for ulcer diseases
ES8801272A1 (es) Procedimiento para preparar compuestos tetraoxo
FI872997A (fi) Amidderivat.
IL73868A (en) N-(aminoethyl)imidazole derivatives,their preparation and pharmaceutical compositions containing them
ES8609288A1 (es) Un procedimiento para preparar un derivado de tiazolidina
DE3561948D1 (en) Oximinophosphoric acid derivatives, process for their preparation and their use as pesticides
IL96730A0 (en) 2-formylbenzylphosphonic acid derivatives,their preparation and their use for the treatment of diseases caused by viruses
ES8600318A1 (es) Procedimiento para la obtencion de esteres de acido fosfonico
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
IL70103A (en) 4-(6,7-dimethoxyquinazolin-4-yl)-semicarbazides,their preparation and pharmaceutical compositions containing them